Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography
- 20 June 2016
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 32 (9) , 1379-1389
Abstract
To evaluate if morphological or functional abnormalities could be detected with echocardiography in hypertrophic myocardiopathy (HCM) mutation carriers without left ventricle (LV) hypertrophy has developed. HCM is caused by extensive genes mutations found in two-third of patients. Because screening for carriership of a large population is unreasonable, identification of asymptomatic subjects is confined to the use of imaging such as echocardiography, by which subtle abnormalities can be detected. Comprehensive echocardiographic studies including morphological and functional assessment were performed. Asymptomatic HCM mutation carriers without hypertrophy (Phe−/Gen+, n = 14), and HCM patients (Phe+/Gen+, n = 17) were compared with healthy control subjects (n = 32) in a prospective design. Compared to controls, septum thickness was significantly higher with an elongated mitral valve in both groups. Thickened LV muscular band (LVMB) are more likely found in Phe−/Gen+ and Phe+/Gen+. The thickness of LVMB was higher in the Phe−/Gen+ versus controls. A LVMB thickness ≥3.6 mm was associated with HCM mutation carriership (sensitivity: 76.9 %, specificity: 94.1 %). The regional strain was significantly impaired in the basal segments of the septum in the Phe−/Gen+. The GLS was significantly impaired in the Phe+/Gen+ (−16.4 % ± 2.9 vs. −21.4 % ± 2.3 in control subjects, p = 0.01). Mitral A wave velocity, septal E/e′, averaged E/e′ were increased in both groups. E/A ratio was significantly lower in Phe+/Gen+. Morphological and functional abnormalities in hypertrophy-free HCM mutation carriers could be detected with echocardiography. Anomalous thickened LVMB could be representing a morphological marker for the HCM disease without overt hypertrophy has developed or in patients with an ambiguous diagnosis.Keywords
This publication has 29 references indexed in Scilit:
- T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular HypertrophyCirculation: Cardiovascular Imaging, 2013
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive SummaryJACC, 2011
- How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2010
- Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosisEuropean Heart Journal - Cardiovascular Imaging, 2008
- Contemporary Definitions and Classification of the CardiomyopathiesCirculation, 2006
- Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient miceCardiovascular Research, 2006
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- The relevance of left ventricular bands.1988
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Left ventricular bands. A normal anatomical feature.Heart, 1984